Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Akso Health (AHG) Common Equity (2017 - 2025)

Akso Health (AHG) has disclosed Common Equity for 8 consecutive years, with $199.1 million as the latest value for Q1 2025.

  • For the quarter ending Q1 2025, Common Equity changed N/A year-over-year to $199.1 million, compared with a TTM value of $199.1 million through Mar 2025, changed N/A, and an annual FY2025 reading of $199.1 million, changed N/A over the prior year.
  • Common Equity was $199.1 million for Q1 2025 at Akso Health, up from $8.8 million in the prior quarter.
  • Across five years, Common Equity topped out at $199.1 million in Q1 2025 and bottomed at $8.8 million in Q1 2023.
  • Average Common Equity over 4 years is $59.4 million, with a median of $14.8 million recorded in 2021.
  • The sharpest move saw Common Equity tumbled 64.09% in 2021, then dropped 28.05% in 2023.
  • Year by year, Common Equity stood at $17.3 million in 2021, then dropped by 28.87% to $12.3 million in 2022, then decreased by 28.05% to $8.8 million in 2023, then soared by 2152.6% to $199.1 million in 2025.
  • Business Quant data shows Common Equity for AHG at $199.1 million in Q1 2025, $8.8 million in Q1 2023, and $12.3 million in Q1 2022.